Закажите звонок

Отправить
×

Спасибо!

Ваша заявка успешно отправлена. В ближайшее время с Вами свяжется наш специалист.
×

List of publications for

×

European Science Review, Issue 1-2/2017

Epidemiology and clinical manifestations of benign prostatic hyperplasia in the Khorezm region

DOI: https://doi.org/10.29013/ESR-17-1.2-145-147

Pages: 145 - 147

Authors: Khudaybergenov U. A., Akilov F. A., Makhmudov A. T.

Abstract: Epidemiologic studies are becoming relevant solution for efficient prophylactic tactics in urological disease treatment and prognosis. This paper is an attempt to highlight regional basis epidemiology of benign prostatic hyperplasia (BPH), particularly in Khorezm Region of Central Asia. This study focused preventive measurements of preventive therapy for the early detection of BPH and reduce the incidence of complications. Output of this study concludes that prevalence of symptoms of BPH increases progressively with age

Keywords: Epidemiology, benign prostatic hyperplasia (BPH), urine flow data

Bibliography:
1. Винаров А. З., Асламазов Э. Г. Гиперплазия предстательной железы. Современное лечение//10 Росс. съезд урологов, материалы. –
М., – 2002. – С. 33–42.
2. Нуруллаев Р. Б. Эпидемиологические аспекты, лечение и профилактика наиболее значимых урологических заболеваний. Автореф.
дисс. д. м.н. – Т., – 2005. – 37 c.
3. Тарасенко Б. В., Клёпов Ю. Ю., Нуруллаев Р. Б. Доброкачественная гиперплазия простаты: распространенность и естественное
развитие заболевания//Проблемы биологии и медицины. – Самарканд, – 2001. – № 4. – С. 7–17.
4. Alcaraz A. et al. Is there evidence of a relation between benign prostatic hyperplasia and prostate cancer?//Eur. Urol. – 2009. – 55:
864–875.
5. Egan K. B. “The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident
Rates”. Urol Clin North Am – 2016. – 43 (3): – P. 289–297.
6. Homma Y., Kawabe K., Tsukamoto T., Yamanaka H., Okada K., Okajima E., Yoshida O., Kumazawa J., Gu F. L., Lee C., Hsu T. C., de
la Cruz R. C., Tantiwang A., Lim P. H., Sheikh M. A., Bapast S. D., Marshall V. R., Tajima K., Aso Y. Epidemiologic survey of lower
urinarytract symptoms in Asia and Australia using the International Prostate Symptom Score//Int Urol – 1997. – P. 40–46.
7. Mohammad R. S. Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Urology
and Nephrology Research center, Shaheed Beheshti University of Medical Sciences, P. O. Box 19395–1849, Tehran, Iran.
8. Kjaerulff T. M., A. K. Ersboll, A. Green M. Emneus E. Pukkala K. Bolin K. Stavem P. Iversen K. Brasso J. Hallas and L. C. Thygesen.
“Patterns of finasteride use in the male populations of four Nordic countries: A cross-national drug utilization study”. Scand J Urol –
2016. – 50 (3): – P. 220–227.
9. Kim E. H., Larson J. A. and Andriole G. L. “Management of Benign Prostatic Hyperplasia”. Annu Rev Med – 2016. – 67: 137–151.
10. Tsukamoto T., Kumamoto Y., Masumori N., Miyakr H., Rhodes T., Girman G. J., Guess H. A., Jacobsen H. J., Lieber M. M. Prevalence
of prostatism in Japanese men in a population based study with comparison to a similar American study//J. Urol – 1995. – 154. – P.
391–395.